Up to now, schizophrenia has mainly been treated symptomatically, as little is known about the exact underlying processes.

We improve our service by using Microsoft Clarity to see how you use our website. By using our site, you agree that we and Microsoft can collect and use this data. Our privacy notice has more details.

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses. A better ...